Description

11-Oxo-2,3,5,11-Tetrahydro-1H-Benzo[4,5]Imidazo[1,2-A]Cyclopenta[D]Pyridine-4-Carbonitrile CAS NO 122062-41-3 is a high-purity, advanced pharmaceutical intermediate characterized by its complex fused heterocyclic structure. This compound is of significant value for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily sought after by research institutions and pharmaceutical manufacturers engaged in the development of new therapeutic agents, particularly within oncology and central nervous system (CNS) drug discovery pipelines.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of proprietary drug candidates and novel chemical entities.
• Organic Synthesis Building Block: Used in research-scale and process chemistry for constructing complex polycyclic frameworks with potential biological activity.
• Medicinal Chemistry Research: A valuable scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Contract Research & Development (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.
• Academic Research: Utilized in university and institutional labs for studying heterocyclic chemistry and developing new synthetic methodologies.

Basic Information

Product Name	11-Oxo-2,3,5,11-Tetrahydro-1H-Benzo[4,5]Imidazo[1,2-A]Cyclopenta[D]Pyridine-4-Carbonitrile
CAS No.	122062-41-3
Molecular Formula	C15H11N3O
Molecular Weight	249.27 g/mol
Synonyms	11-Oxo-2,3,5,11-tetrahydro-1H-benzo[4,5]imidazo[1,2-a]cyclopenta[d]pyridine-4-carbonitrile; 1H-Benzo[4,5]imidazo[1,2-a]cyclopenta[d]pyridine-4-carbonitrile, 2,3,5,11-tetrahydro-11-oxo-; 122062-41-3; Benzo[4,5]imidazo[1,2-a]cyclopenta[d]pyridine-4-carbonitrile, 1,2,3,5,11,11a-hexahydro-11-oxo-; Fused imidazopyridine-carbonitrile derivative
EINECS	Contact for details

Quality Control

Our 11-Oxo-2,3,5,11-Tetrahydro-1H-Benzo[4,5]Imidazo[1,2-A]Cyclopenta[D]Pyridine-4-Carbonitrile is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical research and development. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and physical characteristics is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). This compound may be light-sensitive; prolonged exposure to light should be avoided. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.